JOURNAL ARTICLE
META-ANALYSIS
RESEARCH SUPPORT, NON-U.S. GOV'T
REVIEW
SYSTEMATIC REVIEW
Add like
Add dislike
Add to saved papers

The effect of strength training on performance in endurance athletes.

Sports Medicine 2014 June
BACKGROUND: Economy, velocity/power at maximal oxygen uptake ([Formula: see text]) and endurance-specific muscle power tests (i.e. maximal anaerobic running velocity; vMART), are now thought to be the best performance predictors in elite endurance athletes. In addition to cardiovascular function, these key performance indicators are believed to be partly dictated by the neuromuscular system. One technique to improve neuromuscular efficiency in athletes is through strength training.

OBJECTIVE: The aim of this systematic review was to search the body of scientific literature for original research investigating the effect of strength training on performance indicators in well-trained endurance athletes-specifically economy, [Formula: see text] and muscle power (vMART).

METHODS: A search was performed using the MEDLINE, PubMed, ScienceDirect, SPORTDiscus and Web of Science search engines. Twenty-six studies met the inclusion criteria (athletes had to be trained endurance athletes with ≥6 months endurance training, training ≥6 h per week OR [Formula: see text] ≥50 mL/min/kg, the strength interventions had to be ≥5 weeks in duration, and control groups used). All studies were reviewed using the PEDro scale.

RESULTS: The results showed that strength training improved time-trial performance, economy, [Formula: see text] and vMART in competitive endurance athletes.

CONCLUSION: The present research available supports the addition of strength training in an endurance athlete's programme for improved economy, [Formula: see text], muscle power and performance. However, it is evident that further research is needed. Future investigations should include valid strength assessments (i.e. squats, jump squats, drop jumps) through a range of velocities (maximal-strength ↔ strength-speed ↔ speed-strength ↔ reactive-strength), and administer appropriate strength programmes (exercise, load and velocity prescription) over a long-term intervention period (>6 months) for optimal transfer to performance.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app